Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Phosphatidylinositol 3-Kinases × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Stomatitis 1 Neoplasm Metastasis 1 Mucositis 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 15 Radiotherapy 10 Bevacizumab 6 Irinotecan 5 Everolimus 5 Cyclophosphamide 5 ribociclib 4 Radiation 4 TIC10 compound 3 Re-Irradiation 3 Panobinostat 3 Etoposide 3 Dasatinib 3 pembrolizumab 2 nimotuzumab 2 abemaciclib 2 Vorinostat 2 Valproic Acid 2 Topotecan 2 Specimen Handling 2 Nivolumab 2 Mebendazole 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 GDC-0084 2 Erlotinib Hydrochloride 2 Diphtheria-Tetanus Vaccine 2 Cilengitide 2 Cetuximab 2 1-methyltryptophan 2 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05009992 2025-12-17

PNOC022

University of California, San Francisco

Phase 2 Recruiting

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡